Covid Pill Doesn’t End Need for Vaccinations: Johns Hopkins

Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses test results of Pfizer Inc.’s Covid-19 pill and the lifting of travel restrictions in the U.S. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more:
Connect with us on…